Matthew White (Chief Commercialisation Officer) has decided to leave the Group to pursue an opportunity as Chief Executive Officer of a Cambridge based early-stage medical devices company.
It is currently intended that Mr White will remain with the Company as Chief Commercialisation Officer and an Executive Director of the Company until the end of his six month notice period on 24 March 2026.
The Group is in discussions about a successor and a further update will be issued when appropriate.
Neil Crabb, Frontier IP chief executive officer, said:
I am sorry Matt is leaving the Group. His departure is wholly amicable. In the seven years he has been our Chief Commercialisation Officer, he has played an invaluable role in the progress made by Frontier IP and our portfolio companies. I would like to wish him all the best in the exciting role he is to fulfil. I am sure he will be a great success.
Matthew White, Chief Commercialisation Officer, said:
It has been a privilege to be involved in the development of the Frontier IP portfolio over the last seven years. I look forward to the continued success of the portfolio and Frontier IP’s growing engagement in the Cambridge deeptech ecosystem.